TREM2, microglial and ischemic stroke
- PMID: 37302170
- DOI: 10.1016/j.jneuroim.2023.578108
TREM2, microglial and ischemic stroke
Abstract
Ischemic stroke (IS) is a leading cause of morbidity and mortality worldwide. Immunity and inflammation are key factors in the pathophysiology of IS. The inflammatory response is involved in all stages of stroke, and microglia are the predominant cells involved in the post-stroke inflammatory response. Resident microglia are the main immune cells of the brain and the first line of defense of the nervous system. After IS, activated microglia can be both advantageous and detrimental to surrounding tissue; they can be divided into the harmful M1 types or the neuro-protective M2 type. Currently, with the latest progress of transcriptomics analysis, different and more complex phenotypes of microglia activation have been described, such as disease-related microglia (DAM) associated with Alzheimer's disease (AD), white matter associated microglia (WAMs) in aging, and stroke-related microglia (SAM) etc. The triggering receptor expressed on myeloid cell 2 (TREM2) is an immune-related receptor on the surface of microglia. Its expression increases after IS, which is related to microglial inflammation and phagocytosis, however, its relationship with the microglia phenotype is not clear. This paper reviews the following: 1) the phenotypic changes of microglia in various pathological stages after IS and its relationship with inflammatory factors; 2) the relationship between the expression of the TREM2 receptor and inflammatory factors; 3) the relationship between phenotypic changes of microglia and its surface receptor TREM2; 4) the TREM2-related signalling pathway of microglia after IS and treatment for TREM2 receptor; and finally 5) To clarify the relationship among TREM2, inflammation, and microglia phenotype after IS, as well as the mechanism among them and the some possible treatment of IS targeting TREM2. Moreover, the relationship between the new phenotype of microglia such as SAM and TREM2 has also been systematically summarized, but there are no relevant research reports on the relationship between TREM2 and SAM after IS.
Keywords: Immunity and inflammation; Ischemic stroke; Microglia phenotype; TREM2.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflict of interest.
Similar articles
-
The versatile role of TREM2 in regulating of microglia fate in the ischemic stroke.Int Immunopharmacol. 2022 Aug;109:108733. doi: 10.1016/j.intimp.2022.108733. Epub 2022 May 4. Int Immunopharmacol. 2022. PMID: 35525233 Review.
-
Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.J Neurosci. 2015 Feb 25;35(8):3384-96. doi: 10.1523/JNEUROSCI.2620-14.2015. J Neurosci. 2015. PMID: 25716838 Free PMC article.
-
Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.Neurochem Res. 2019 May;44(5):1138-1151. doi: 10.1007/s11064-019-02748-x. Epub 2019 Feb 12. Neurochem Res. 2019. PMID: 30756214
-
TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury.Biomed Pharmacother. 2024 Jan;170:115962. doi: 10.1016/j.biopha.2023.115962. Epub 2023 Dec 1. Biomed Pharmacother. 2024. PMID: 38042110
-
Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.Neuroscientist. 2023 Jun;29(3):302-316. doi: 10.1177/10738584211040786. Epub 2021 Sep 2. Neuroscientist. 2023. PMID: 34470515 Free PMC article. Review.
Cited by
-
Unveiling the significance of TREM1/2 in hemorrhagic stroke: structure, function, and therapeutic implications.Front Neurol. 2024 Feb 7;15:1334786. doi: 10.3389/fneur.2024.1334786. eCollection 2024. Front Neurol. 2024. PMID: 38385036 Free PMC article. Review.
-
The global burden of lead exposure-related ischemic stroke: based on Bayesian age-period-cohort analysis.Front Public Health. 2025 Jul 16;13:1608129. doi: 10.3389/fpubh.2025.1608129. eCollection 2025. Front Public Health. 2025. PMID: 40740352 Free PMC article.
-
CMPK2 promotes microglial activation through the cGAS-STING pathway in the neuroinflammatory mechanism.Sci Rep. 2025 Apr 7;15(1):11807. doi: 10.1038/s41598-025-97232-8. Sci Rep. 2025. PMID: 40189684 Free PMC article.
-
Are Ischemic Stroke and Alzheimer's Disease Genetically Consecutive Pathologies?Biomedicines. 2023 Oct 8;11(10):2727. doi: 10.3390/biomedicines11102727. Biomedicines. 2023. PMID: 37893101 Free PMC article. Review.
-
The dual role of microglia in Alzheimer's disease: from immune regulation to pathological progression.Front Aging Neurosci. 2025 Mar 27;17:1554398. doi: 10.3389/fnagi.2025.1554398. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40212564 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
